Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Medical Devices
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > No follow through
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by stockhunter1on Jan 13, 2021 10:44am
323 Views
Post# 32284419

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:No follow through

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:No follow throughhttps://themarketherald.ca/sernova-tsxvsva-slated-to-release-clinical-trials-amid-share-price-surge-2021-01-11/

Redbaron this media write up will surely help you "stay positive" !! as we are REVALUED!!!  I find it  entertaining reading the posts from the ones with "motives" as they try and create negative sentiment constantly, not so easy to manipulate Sernova now EH...Eh? Personally my smile is huge watching this Canadian BIOTECK story unfold...to be sure it is NOW being told...Thursday...Dr. Tolekis at J.P. Morgan and the drum roll for Friday goes to Dr. Witkowski at ASTS...interesting times are here, need I say more?  OH yes...so excited I nearly forgot. CONGRATULATIONS TO ALL LONGS!!! 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities